These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11979860)

  • 1. [Proton pump inhibitors: Omeprazole].
    Iwasaki A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():633-9. PubMed ID: 11979860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
    Kawata H; Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():640-4. PubMed ID: 11979862
    [No Abstract]   [Full Text] [Related]  

  • 3. [New triple therapy for Helicobacter pylori infection].
    Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():414-9. PubMed ID: 11979817
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)].
    Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():627-31. PubMed ID: 11979859
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proton pump inhibitors: Rabeprazole].
    Yoshino J
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():645-9. PubMed ID: 11979863
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
    Nagahara A; Miyazaki A; Miwa H; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():435-8. PubMed ID: 11979822
    [No Abstract]   [Full Text] [Related]  

  • 7. [Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
    Ohkusa T; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():431-4. PubMed ID: 11979821
    [No Abstract]   [Full Text] [Related]  

  • 8. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy.
    Mégraud F
    Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S35-7; discussion S43-5. PubMed ID: 10503821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [H. pylori eradication therapy and natural history of peptic ulcer].
    Haruma K; Kamada T; Kusunoki H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():49-53. PubMed ID: 11979833
    [No Abstract]   [Full Text] [Related]  

  • 11. [Eradication of Helicobacter pylori].
    Herszényi L
    Orv Hetil; 2003 Oct; 144(40):1991-2. PubMed ID: 14626641
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA
    Eksp Klin Gastroenterol; 2004; (3):40-4. PubMed ID: 15560400
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of clarithromycin in eradicating Helicobacter pylori.
    Satoh K; Kimura K; Takimoto T; Kihira K; Taniguchi Y; Saifuku K
    J Gastroenterol; 1996 Nov; 31 Suppl 9():53-5. PubMed ID: 8959520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
    Kagaya H; Kato M; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():455-9. PubMed ID: 11979827
    [No Abstract]   [Full Text] [Related]  

  • 17. [Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice].
    Sugano K
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():32-7. PubMed ID: 11989260
    [No Abstract]   [Full Text] [Related]  

  • 18. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
    J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
    Inoue K; Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():460-4. PubMed ID: 11979828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.